{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Theratechnologies Inc."},"Symbol":{"label":"Symbol","value":"THTX"},"Address":{"label":"Address","value":"2015, RUE PEEL,5E ETAGE, MONTREAL, Quebec, H3A 1T8, Canada"},"Phone":{"label":"Phone","value":"+1 514 336-7800"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States."},"CompanyUrl":{"label":"Company Url","value":"https://www.theratech.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Christian Marsolais","title":"Chief Medical Officer & Senior Vice President"},{"name":"Paul LÃ©vesque","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}